| mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
-0.0086 |
0.9 |
| mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
| mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.0067 |
0.9 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.9 |
| mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
0.0078 |
0.9 |
| mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0067 |
0.9 |
| mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
| mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.9 |
| mRNA |
AZD-7545 |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.9 |